PROVIDER PROFILE · NPI 1598721284

John LeeMD

Internal MedicineFullerton, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,305

Unique beneficiaries

—

Total services

2,892

Distinct HCPCS

Medicare payment

$186K

Peer benchmark

Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).

PRESCRIBING · PART D · 2024

Total Rx claims

20,660

Beneficiaries

—

Total drug cost

$2.1M

Distinct drugs

172

Brand share

23.9%

Top prescribed drugs

Atorvastatin Calcium2,745 claims

Losartan Potassium1,372 claims

Amlodipine Besylate1,245 claims

Rosuvastatin Calcium648 claims

Alendronate Sodium527 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

100.0

Cost

85.9

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

1.05%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$156

Payment records

By payment type

Food and Beverage$156

Top paying entities

Food and Beverage$156

REFERRAL NETWORK

Where John Lee's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Paul Lee Ophthalmology · Garden Grove, CA	26	64
Unilab Corporation Clinical Laboratory · West Hills, CA	17	85
Chin Kim Internal Medicine · Anaheim, CA	15	42
ST JUDE HOSPITAL INC	14	30
Sung Yoo Gastroenterology · Diamond Bar, CA	14	67

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history